Literature DB >> 30205795

Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases.

Anna Aiello1, Giuseppina Candore1, Giulia Accardi1, Calogero Caruso1, Claudia Colomba2, Giovanni Duro3, Caterina Maria Gambino1, Mattia Emanuela Ligotti1, Danilo Di Bona4.   

Abstract

Killer immunoglobulin-like receptors (KIRs) regulate the activation of natural killer cells through their interaction with human leucocyte antigens (HLA). KIRs and HLA loci are highly polymorphic, and some of their combinations have been found to protect against viral infections or to predispose to autoimmune disorders. In particular, some activating KIRs profiles may be detrimental in autoimmune pathogenesis, and specific KIRs may be particularly aggressive in the clearance of different microorganisms, protecting individuals in the control of a given pathogen. So, considering that in the pathogenesis of many autoimmune disorders and infections innate immunity plays a key role, the recent development for KIRs characterization, diseases monitoring, and treatment becomes obvious. Here, we reviewed a growing body of evidence supporting the influence of KIRs variants and their interaction with ligands in the development of the main human autoimmune and viral diseases, highlighting the main applications in clinical practice. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Autoimmune diseases; HLA ligands; KIRs; immunogenetics; translational medicine; viral infections.

Mesh:

Substances:

Year:  2018        PMID: 30205795     DOI: 10.2174/1381612824666180911123249

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  3 in total

1.  The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans.

Authors:  Danilo Di Bona; Janardan P Pandey; Anna Aiello; Massimo Bilancia; Giuseppina Candore; Calogero Caruso; Claudia Colomba; Giovanni Duro; Mattia Emanuela Ligotti; Luigi Macchia; Sergio Rizzo; Giulia Accardi
Journal:  Immunology       Date:  2019-11-12       Impact factor: 7.397

2.  Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.

Authors:  David J Margolis; Nandita Mitra; Ole J Hoffstad; Brian S Kim; Dimitri S Monos; Elizabeth J Phillips
Journal:  J Immunol       Date:  2021-08-18       Impact factor: 5.426

Review 3.  The Role of Immunogenetics in COVID-19.

Authors:  Fanny Pojero; Giuseppina Candore; Calogero Caruso; Danilo Di Bona; David A Groneberg; Mattia E Ligotti; Giulia Accardi; Anna Aiello
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.